Senate renews battle over stem cell funding

The Senate Appropriations Committee has fired back against President Bush's veto of increased federal funding for stem cell research by pushing new legislation that would greatly expand the number of cell lines that qualify for government research support. And supporters forecast a blizzard of new legislative moves that will keep this issue front and center in Washington. The Democrats clearly intend to make this a permanent feature of the political landscape, confident that they can leverage broad public support into votes during the 2008 election. President Bush, of course, has made it clear that the presidency won't budge an inch on the issue--at least until January 20, 2009, his last day in office.

- read the report from the San Francisco Chronicle

ALSO: In the House, meanwhile, lawmakers passed a PDUFA bill that drops the DTC and marketing restrictions industry lobbyists had railed against. Report

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.